Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

SciSparc Shareholders Approve February Governance Agenda

Tipranks - Tipranks - Thu Feb 5, 3:46PM CST

Claim 50% Off TipRanks Premium

SciSparc Ltd. ( (SPRC) ) has shared an update.

Shareholders approved all proposals presented at the February 4, 2026 special general meeting, affirming SciSparc’s governance agenda and regulatory compliance plan, which may streamline future capital and operational initiatives by ensuring alignment with Israeli corporate law and existing SEC-registered offerings.

More about SciSparc Ltd.

SciSparc Ltd. is an Israel-based specialty pharmaceutical company developing cannabinoid-based therapies for central nervous system disorders, targeting regulatory-compliant clinical applications in global markets.

Average Trading Volume: 2,100,213

Technical Sentiment Signal: Sell

Current Market Cap: $3.35M

For a thorough assessment of SPRC stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Trending Articles

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).